NCT02020707 2024-07-26Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological CancersMayo ClinicPhase 1 Completed43 enrolled
NCT02286219 2017-09-18Phase 1, Multiple Ascending Dose Study of Anti-HER2 FCAB FS102 in HER2 Positive Solid Tumors (Anti HER2 Fcab)Bristol-Myers SquibbPhase 1 Completed30 enrolled